My Watchlist

Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

2

The 2 Biotechs Ramping Up Sales

By | More Articles
January 10, 2012 | Comments (2)

The following video is part of our "Motley Fool Conversations" series, in which David Williamson, health-care editor and analyst, and Austin Smith, consumer-goods editor and analyst, discuss topics around the investing world.

In today's edition, David and Austin discuss the big Q4 pre-releases that came out ahead of the JPMorgan Annual Healthcare Conference. Positive operational updates sent shares soaring by double digits for a pair of biotechs that struggled mightily in 2011. Find out more in the video.

Biotech investors are always looking for the next runaway success. Motley Fool co-founder David Gardner has recently identified a small-cap health-care company that he believes is poised for monster returns. To find out which stock is about to reap huge profits from fundamentally changing its industry, download our exclusive special free report, "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Austin Smith has no positions in the stocks mentioned above. David Williamson owns shares of Dendreon. The Motley Fool owns shares of Dendreon. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (2) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 11, 2012, at 5:59 PM, SCinv69 wrote:

    Hey David,

    I am new to following the biotech sector. How do you explain what happened today? (1/11/2012)

  • Report this Comment On January 11, 2012, at 6:01 PM, SCinv69 wrote:

    With Dendreon that is

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1755854, ~/Articles/ArticleHandler.aspx, 5/20/2013 3:24:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 15,354.40 121.18 0.80%
S&P 500 1,667.47 17.00 1.03%
NASD 3,498.97 33.73 0.97%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/17/2013 3:59 PM
ITMN $9.99 Down -0.31 -3.01%
InterMune CAPS Rating: **
DNDN $4.01 Up +0.04 +1.01%
Dendreon Corp CAPS Rating: **
SVNT $0.56 Down -0.01 -1.75%
Savient Pharmaceut… CAPS Rating: **
MDVN $47.53 Down -0.76 -1.57%
Medivation, Inc. CAPS Rating: **

Advertisement